Plasma Therapy Market Forecast Report | Size, Share & Growth Drivers 2030
[Research Report] The plasma therapy market size is expected to grow from US$ 390.25 million in 2022 to US$ 1,097.64 million by 2030; the market is estimated to register a CAGR of 13.80% from 2022 to 2030.
Analyst’s Viewpoint
The plasma therapy market analysis explains growth drivers such as the rising cases of orthopedic disorders in people, especially in the geriatric population; rising number of joint and muscle injuries in athletes, and surging demand for minimally invasive cosmetic procedures. Further, the customization of plasma therapies according to patients’ needs is expected to introduce new trends in the market during 2022–2030.
Plasma therapy, also termed as platelet-rich plasma (PRP) therapy, entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair. The growth factors present in PRP effectively stimulate the regeneration of tissues, thereby expediting the healing of injuries or enhancing mechanisms involved in aesthetic procedures.
Market Insights
Rising Cases of Orthopedic Disorders & Muscle Injuries and Increasing Use of PRP in Aesthetic Procedures Fuel Plasma Therapy Market
According to statistics published by the World Health Organization (WHO) in 2023, ~528 million people across the world were living with osteoarthritis (OA) in 2019, representing an increase of 113% since 1990. An article published in PubMed Central in December 2020 states that the use of PRP offers potential for tissue repair due to the abundance of growth factors and cytokines in this plasma, which are crucial in initiating and modulating regenerative microenvironments for both soft and hard tissues. PRP therapy can be used in the healing of bone fractures; ligament, muscle, and tendon injuries; peripheral nerve injuries; articular cartilage lesions; and osteoarthritis. Therefore, there is a high demand for plasma therapies in orthopedic and tissue repair procedures.
Moreover, PRP is used in cosmetic surgeries for skin rejuvenation, anti-aging, and other aesthetic procedures. Out of 73 studies evaluated in a review published in PubMed Central in November 2021, 45 studies focused on PRP monotherapy, while 35 studies investigated the effects of PRP in combination with micro needling. As a result, the therapies were well-tolerated and suitable for all phototypes. Positive treatment outcomes were identified for various conditions, including skin rejuvenation, scar revision, alopecia, pigmentary disorders, lichen scleroses, leprosy-induced peripheral neuropathy, plaque psoriasis, and nail disorders.
Therefore, the use of PRP in cosmetic surgeries contributes to the growth of the plasma therapy market.
Future Trend
Customization Options to Introduce Patient-Centric Therapies Emerge as Future Trend in Plasma Therapy Market
Customized plasma therapy entails personalizing plasma therapies to meet patients’ needs based on factors such as their specific medical conditions and genetic makeup. Customization efforts are focused on improving the efficacy of plasma therapy by tailoring the composition of components such as antibodies and proteins to treat the specific health condition of the patient more effectively. Researchers and healthcare professionals are implementing their expertise to come up with ways to tailor plasma therapy to specific ailments such as autoimmune disorders, infectious diseases, and rare cancer types. Companies such as Regenexx and Bridging Biosciences provide highly pure and concentrated PRP customizable to eliminate inconsistencies for healing of tissue damage and cell regeneration. USA Medical Research Institute in Texas offers PRP TruDose therapy, which contains personalized therapeutic doses for the treatment of various chronic pain for musculoskeletal conditions, LUPUS, food sensitivities, Lyme disease, and many degenerative conditions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Therapy Market: Strategic Insights
Plasma Therapy Market
-
CAGR (2022 - 2030)
13.80%
-
Market Size 2022
US$ 390.25 Million
-
Market Size 2030
US$ 1,097.64 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Biotest
- CSL Ltd
- Grifols
- Kedrion S p A
- China Biologics Inc
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
Source
- Autologous and Allogeneic
Application
- Orthopedic Conditions
- Dermatology
- Dental Issues
End User
- Hospitals and Clinics
- Research Institutes
- Ambulatory Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Therapy Market: Strategic Insights
-
CAGR (2022 - 2030)13.80% -
Market Size 2022
US$ 390.25 Million -
Market Size 2030
US$ 1,097.64 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Biotest
- CSL Ltd
- Grifols
- Kedrion S p A
- China Biologics Inc
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Autologous and Allogeneic
- Orthopedic Conditions
- Dermatology
- Dental Issues
- Hospitals and Clinics
- Research Institutes
- Ambulatory Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Segmentation and Scope
Type-Based Insights
Based on type, the plasma therapy market is segmented into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Leukocyte-rich PRP (LR-PRP) is a type of PRP that has a higher concentration of neutrophils (white blood cells) than the baseline level. It is generally associated with proinflammatory effects. However, in some cases, LR-PRP can be beneficial to stimulate inflammation in the body to indicate a chronic condition such as tendinopathy.
Source-based Insights
The plasma therapy market, based on source, is bifurcated into autologous and allogeneic. The autologous segment dominated the market in 2020.
Application-based Insights
The plasma therapy market, by application, is segmented into orthopedic conditions, dermatology, dental issues, and others. The dermatology segment held the largest market share in 2022.
End User-Based Insights
In terms of end user, the plasma therapy market is categorized as hospitals and clinics, research institutes, ambulatory surgical centers (ASCs), and others. The hospital segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during 2022–2030.
Plasma Therapy Market Report Scope
Report Attribute
Details
Market size in 2022
US$ 390.25 Million
Market Size by 2030
US$ 1,097.64 Million
Global CAGR (2022 - 2030)
13.80%
Historical Data
2020-2022
Forecast period
2022-2030
Segments Covered
By Type - Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
By Source - Autologous and Allogeneic
By Application - Orthopedic Conditions
- Dermatology
- Dental Issues
By End User - Hospitals and Clinics
- Research Institutes
- Ambulatory Surgical Centers
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
- Biotest
- CSL Ltd
- Grifols
- Kedrion S p A
- China Biologics Inc
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 390.25 Million |
Market Size by 2030 | US$ 1,097.64 Million |
Global CAGR (2022 - 2030) | 13.80% |
Historical Data | 2020-2022 |
Forecast period | 2022-2030 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis
North America dominated the plasma therapy market in 2022. It is further expected to record the highest CAGR in the market during 2022–2030. The market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share of the global plasma therapy market. Market growth in the country is attributed to the burgeoning adoption of platelet-rich plasma (PRP) in orthopedic and cosmetic surgeries, rising investments in the healthcare sector, dynamics research and development landscape, and USFDA approval for selected PRP therapies.
The report profiles leading players operating in the global plasma therapy market. These include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc. These leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.
Key Developments by Major Market Players are:
- In March 2023, BioLife Plasma Services announced the opening of its plasma donation center in the US with new locations in West Springfield (Massachusetts) and Pearland (Texas). This expansion would help the company expand its business network.
- In February 2021, Atlas Health Medical Group launched the SkinPen. This small pen-shaped microneedling device containing PRP for facelifts punctures the skin and stimulates an anti-aging response.
- In March 2020, Takeda Pharmaceutical Company Limited initiated the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-Ig) to treat individuals suffering from severe COVID-19.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Source, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The plasma therapy market majorly consists of the players such include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc.
Global plasma therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the plasma therapy market in 2022.
The CAGR value of the plasma therapy market during the forecasted period of 2020-2030 is 13.80%.
Plasma therapy entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair. The growth factors present in PRP effectively stimulate the regeneration of tissues, thereby expediting the healing of injuries or enhancing mechanisms involved in aesthetic procedures.
The orthopedic conditions segment dominated the global plasma therapy market and held the largest market share of 35.31% in 2022.
The rising cases of orthopedic disorders in people, especially in the geriatric population; rising number of joint and muscle injuries in athletes, and surging demand for minimally invasive cosmetic procedures.
The List of Companies - Plasma Therapy Market
- Biotest
- CSL Ltd.
- Grifols
- Kedrion S.p.A
- China Biologics, Inc.
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
- China Biologics Products